is tirzepatide still on shortage list Ends is tirzepatide on shortage list

The FDA Declines to Approve Bydureon, a New Once-Weekly GLP-1 Agonist by ben kozak Amylin Pharmaceuticals and Eli Lilly, the makers of Byetta, the first ever GLP-1 agonist, have teamed up again to develop a brand new GLP-1 agonist, which they have named Bydureon

The pill is easier to make, so it could be more accessible than the injectables, which were often in short supply

Counterfeit and unregulated products may contain incorrect doses, contaminants, or no active ingredient at all

Look for multi-strain probiotics with at least 10 billion CFU

Losing insurance coverage and stopping overnight

Wegovy, used for weight management, alters the digestive system considerably, influencing the gut microbiome